Abstract
Neuronal-type nitric oxide synthase (NOS I) is involved in ischemia-induced brain damage, and glucocorticoids have been reported to protect from brain damage. This prompted us to investigate if the activity or expression of NOS I was influenced by glucocorticoids. We used the murine neuroblastoma cell line N1E-115 as our experimental model. Short-term incubation (30 min) of the N1E-115 cells with dexamethasone (10 nm to 1 μm) or hydrocortisone (100 nm to 10 μm) did not change the enzymatic activity of NOS I. However, the glucocorticoids inhibited NOS I mRNA expression in a concentration-dependent fashion (down to 53.3 ± 2.5% of control). In time-course experiments with 100 nm dexamethasone, maximum down-regulation of NOS I mRNA was seen after 24 hr (55.6 ± 6.3% of control). Similar effects were seen with 10 μm hydrocortisone. The effect of 100 nm dexamethasone was completely reversed by 1 μm of the glucocorticoid receptor antagonist mifepristone. In experiments with actinomycin D (10 μg/ml), the half-life of the NOS I mRNA was determined to be approximately 12 hr and remained unchanged after glucocorticoid incubation. Nuclear run-on analyses indicated that the decrease in NOS I mRNA was the result of a glucocorticoid-induced inhibition of NOS I gene transcription. In Western blots, the 160-kDa NOS I protein band was down-regulated to 68.5 ± 8.4% of control after an incubation of the N1E-115 cells with 100 nm dexamethasone for 26 hr. Similarly, NO production was down-regulated to 57.8 ± 8.7% of control. These data demonstrate that glucocorticoids reduce the expression of NOS I without changing its activity.
Footnotes
- Received January 22, 1998.
- Accepted May 5, 1998.
-
Send reprint requests to: Dr. Petra M. Schwarz, Department of Pharmacology, Johannes Gutenberg University, Obere Zahlbacher Strasse 67, 55101 Mainz, Germany. E-mail:petra.schwarz{at}uni-mainz.de
-
This work was supported by Grants Fo 144/3–2 and SFB 553 (Project A1) from the Deutsche Forschungsgemeinschaft (Bonn, Germany) and by a grant from the Ministry of the Environment of the State of Rhineland-Palatinate (Mainz, Germany). This article is part of the thesis work of B.G.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|